Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Arts-Way Manufacturing Co
ARTW
$14.9M
| $117K | ﹤0.01% |
49,674
+25,174
| +103% | +$53.1K |
|
3252
Jerash Holdings
JRSH
$67.7M
| $117K | ﹤0.01% |
24,084
+2,600
| +12% | +$12.3K |
|
3253
GigaMedia
GIGM
$16.7M
| $115K | ﹤0.01% |
+36,350
| New | +$94.7K |
|
3254
Ranger Energy Services
RNGR
$405M
| $115K | ﹤0.01% |
38,987
+6,700
| +21% | +$24.1K |
|
3255
VolitionRx Ltd
VNRX
$7.6M
| $112K | ﹤0.01% |
+1,439
| New | +$104K |
|
3256
Arbutus Biopharma
ABUS
$906M
| $111K | ﹤0.01% |
+61,207
| New | +$100K |
|
|
CD
3257
Chaince Digital Holdings
CD
$377M
| $111K | ﹤0.01% |
43,462
+6,746
| +18% | +$12.3K |
|
|
MRNS
3258
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $111K | ﹤0.01% |
+10,950
| New | +$101K |
|
|
ESBK
3259
DELISTED
Elmira Savings Bank Elmira NY
ESBK
| $111K | ﹤0.01% |
10,068
-3,574
| -26% | -$42.1K |
|
3260
Capital Bancorp
CBNK
$616M
| $110K | ﹤0.01% |
10,274
-17,600
| -63% | -$190K |
|
|
CWBR
3261
DELISTED
CohBar, Inc. Common Stock
CWBR
| $110K | ﹤0.01% |
+2,365
| New | +$165K |
|
|
CYAD
3262
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
| $110K | ﹤0.01% |
+10,300
| New | +$101K |
|
3263
DarioHealth
DRIO
$71.5M
| $109K | ﹤0.01% |
+855
| New | +$114K |
|
3264
Ramaco Resources Class A
METC
$667M
| $108K | ﹤0.01% |
52,268
+31,215
| +148% | +$73.9K |
|
3265
Myomo
MYO
$57.8M
| $107K | ﹤0.01% |
29,022
+12,100
| +72% | +$47.2K |
|
3266
Rockwell Medical
RMTI
$30.9M
| $107K | ﹤0.01% |
497
-159
| -24% | -$37.6K |
|
|
SOS
3267
SOS Limited
SOS
$16.7M
| $106K | ﹤0.01% |
51
+4
| +9% | +$4.64K |
|
3268
Sphere 3D
ANY
$18M
| $105K | ﹤0.01% |
+525
| New | +$63K |
|
|
KUST
3269
Kustom Entertainment Inc
KUST
$859K
| – | – |
0
| – | – |
|
3270
Vuzix
VUZI
$220M
| $105K | ﹤0.01% |
+44,100
| New | +$91.2K |
|
|
NVNO
3271
enVVeno Medical
NVNO
$7.41M
| $104K | ﹤0.01% |
+309
| New | +$102K |
|
|
NHLD
3272
DELISTED
National Holdings Corporation
NHLD
| $104K | ﹤0.01% |
52,108
+1,800
| +4% | +$3.27K |
|
3273
Riley Exploration Permian
REPX
$786M
| $101K | ﹤0.01% |
15,216
+1,659
| +12% | +$10.7K |
|
3274
One Stop Systems
OSS
$327M
| $100K | ﹤0.01% |
50,700
-8,210
| -14% | -$13.6K |
|
|
SELF
3275
Global Self Storage
SELF
$58.9M
| $100K | ﹤0.01% |
26,000
+6,500
| +33% | +$24.8K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.